Registry for coronary artery disease and microvascular disease in cardiomyopathies
Official title: Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Run by University Hospital, Grenoble · NCT03479580 · Data updated 2026-11-12
This study is trying to see how blockages in the heart's blood vessels affect the health and future of people with different types of heart muscle diseases.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1600 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (La Tronche) |
| Status | Recruiting |
| Started | February 8, 2018 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | May 19, 2022 |
| Trial ID | NCT03479580 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with ischemic, dilated, hypertrophic, or restrictive cardiomyopathy.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or under legal protection will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry evaluates the long-term prognostic value of macrovascular and microvascular coronary artery stenoses in patients with various types of cardiomyopathy, including ischemic, hypertrophic, dilated, and restrictive forms. The study utilizes advanced imaging techniques such as coronary angiography, cardiac magnetic resonance, and single-photon emission computed tomography to assess the incidence and prognosis of bystander coronary artery disease and microvascular disease. Conducted across five centers in France, the study aims to clarify the impact of these conditions on patient outcomes.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of coronary artery disease's impact on cardiomyopathy prognosis, leading to improved patient management.
How similar studies have gone: While the study explores a novel approach to understanding the prognostic implications of coronary artery disease in cardiomyopathy, similar studies have shown promise in utilizing advanced imaging techniques for cardiovascular assessment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ischemic * Dilated * Hypertrophic * Restrictive cardiomyopathy. Exclusion Criteria: * Pregnant women * Breastfeeding women * Patients under legal protection
Where it's running
-
University Hospital Grenoble
La Tronche, France Recruiting
Study contacts
- Principal investigator: Gilles BARONE-ROCHETTE, PI — University Hospital, Grenoble
- Study coordinator: Clémence CHARLON
- Email: ccharlon@chu-grenoble.fr
- Phone: 0033476766652
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ATR 1072 in PRKAG2 Syndrome
A first-in-human study tests ATR 1072 to see if it is safe and how it behaves in adults with PRKAG2 Syndrome.
-
Apixaban with or without Clopidogrel in stroke patients with NVAF and intracranial/extracranial atherosclerosis
This study tests whether adding clopidogrel to apixaban is safe and helpful for people with acute ischemic stroke due to non-valvular atrial fibrillation and atherosclerosis.
-
Registry for patients with non-ischemic cardiomyopathies
This study is collecting information from people with non-ischemic cardiomyopathies to see how to better diagnose and manage their condition and predict potential heart rhythm problems.
-
Improving heart assessment in fetuses and newborns
This study is testing new ways to check the heart health of unborn babies and newborns to help prevent serious problems during delivery.
-
Registry collecting data on cardiac PET and CardioFlux Magnetocardiography for coronary ischemia detection
This study is collecting information from patients who might have coronary ischemia to see if a new heart imaging method can help find this condition better than the standard tests.
-
Using platelet expression and blood flow analysis to predict recurrent stroke risk
This study is trying to see if certain blood cell markers and blood flow patterns can help predict the risk of having another stroke in people who have already had a minor stroke or a temporary stroke-like event.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.